Mahendra Patel
Vorstandsvorsitzender bei Navinta LLC
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Michael Keenley | M | - |
Zydus Pharmaceuticals (USA), Inc.
 Zydus Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Zydus Pharmaceuticals (USA), Inc. is a globally integrated generic pharmaceutical company. It manufactures tablets, capsules, soft gel, sterile liquids, injectables, inhalers, topicals, and trans-dermal patch dosage forms. The firm's products include generic name, brand equipment, dosage form, and therapeutic category. The company was founded in August 2005 and is headquartered in Pennington, NJ. | - |
| Joseph Renner | M | - |
Zydus Pharmaceuticals (USA), Inc.
Zydus Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Zydus Pharmaceuticals (USA), Inc. is a globally integrated generic pharmaceutical company. It manufactures tablets, capsules, soft gel, sterile liquids, injectables, inhalers, topicals, and trans-dermal patch dosage forms. The firm's products include generic name, brand equipment, dosage form, and therapeutic category. The company was founded in August 2005 and is headquartered in Pennington, NJ. | - |
| Namita Vikas Thapar | F | 47 |
Emcure Pharmaceuticals Ltd.
 Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 18 Jahre |
| Elizabeth Purcell | F | - |
Zydus Pharmaceuticals (USA), Inc.
Zydus Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Zydus Pharmaceuticals (USA), Inc. is a globally integrated generic pharmaceutical company. It manufactures tablets, capsules, soft gel, sterile liquids, injectables, inhalers, topicals, and trans-dermal patch dosage forms. The firm's products include generic name, brand equipment, dosage form, and therapeutic category. The company was founded in August 2005 and is headquartered in Pennington, NJ. | - |
| Vikas Thapar | M | 50 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 18 Jahre |
| Dharmishtaben N. Raval | F | 68 |
Zydus Pharmaceuticals (USA), Inc.
Zydus Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Zydus Pharmaceuticals (USA), Inc. is a globally integrated generic pharmaceutical company. It manufactures tablets, capsules, soft gel, sterile liquids, injectables, inhalers, topicals, and trans-dermal patch dosage forms. The firm's products include generic name, brand equipment, dosage form, and therapeutic category. The company was founded in August 2005 and is headquartered in Pennington, NJ. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Marvin Samson | M | 82 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | - |
| Amit Dixit | M | 51 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | - |
| Rodger Novak | M | 56 |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | 2 Jahre |
| David Epstein | M | 62 |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | 11 Jahre |
| Kedar Purushottam Phadke | M | - |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Indien | 5 | 45,45% |
| Vereinigte Staaten | 4 | 36,36% |
| Schweiz | 2 | 18,18% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Mahendra Patel
- Persönliches Netzwerk
